107 related articles for article (PubMed ID: 10779646)
21. [Detection of p27/kip1 mRNA in blood cells by nonradioactive ribonuclease protection assay].
Okamoto Y; Nakabayashi H; Kikukawa S; Nakano H
Rinsho Byori; 1996 May; 44(5):483-6. PubMed ID: 8676570
[TBL] [Abstract][Full Text] [Related]
22. [The expression and localization of p27(KIP1)-GFP fusion gene in hepatocellular carcinoma cell lines].
Zheng JY; Li J; Li KZ; Wang WL; Wang WZ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 May; 19(3):218-20. PubMed ID: 15155074
[TBL] [Abstract][Full Text] [Related]
23. Low levels of cyclin D and nonfunctional Rb protein affect cdk6 association with cyclin-dependent kinase inhibitor p27(Kip1).
Kwon TK; Park JW
Biochem Biophys Res Commun; 2001 Jun; 284(1):106-11. PubMed ID: 11374878
[TBL] [Abstract][Full Text] [Related]
24. Reduced expression of p27(Kip1) protein in relation to salivary adenoid cystic carcinoma metastasis.
Takata T; Kudo Y; Zhao M; Ogawa I; Miyauchi M; Sato S; Cheng J; Nikai H
Cancer; 1999 Sep; 86(6):928-35. PubMed ID: 10491517
[TBL] [Abstract][Full Text] [Related]
25. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
26. Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells.
Motomura W; Takahashi N; Nagamine M; Sawamukai M; Tanno S; Kohgo Y; Okumura T
Int J Cancer; 2004 Jan; 108(1):41-6. PubMed ID: 14618613
[TBL] [Abstract][Full Text] [Related]
27. p16INK4 gene mutation and allelic loss of chromosome 9p21-22 in Taiwanese hepatocellular carcinoma.
Chen TC; Hsieh LL; Kuo TT; Ng KF; Wu Chou YH; Jeng LB; Chen MF
Anticancer Res; 2000; 20(3A):1621-6. PubMed ID: 10928081
[TBL] [Abstract][Full Text] [Related]
28. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
[TBL] [Abstract][Full Text] [Related]
29. Persistent and heterogenous expression of the cyclin-dependent kinase inhibitor, p27KIP1, in rat hearts during development.
Koh KN; Kang MJ; Frith-Terhune A; Park SK; Kim I; Lee CO; Koh GY
J Mol Cell Cardiol; 1998 Mar; 30(3):463-74. PubMed ID: 9515024
[TBL] [Abstract][Full Text] [Related]
30. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors.
Sui L; Tokuda M; Ohno M; Hatase O; Hando T
Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035
[TBL] [Abstract][Full Text] [Related]
31. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
Guo Y; Sklar GN; Borkowski A; Kyprianou N
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
[TBL] [Abstract][Full Text] [Related]
32. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features.
Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ
Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796
[TBL] [Abstract][Full Text] [Related]
33. p27(Kip1) loss does not predict survival in patients with advanced gastric carcinoma.
Feakins RM; Mulcahy HE; Quaglia A; Jawhari A; Zhang Z; Patchett SE
Cancer; 2000 Oct; 89(8):1684-91. PubMed ID: 11042561
[TBL] [Abstract][Full Text] [Related]
34. Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia.
Stegmaier K; Takeuchi S; Golub TR; Bohlander SK; Bartram CR; Koeffler HP
Cancer Res; 1996 Mar; 56(6):1413-7. PubMed ID: 8640833
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase inhibitor p27(Kip1) expression in transitional cell carcinoma of renal pelvis and ureter.
Masuda M; Takano Y; Iki M; Makiyama K; Ikeda I; Noguchi S; Hasegawa Y; Hosaka M
Cancer Lett; 2000 Mar; 150(2):183-9. PubMed ID: 10704741
[TBL] [Abstract][Full Text] [Related]
36. p27(Kip1) induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells.
Kolluri SK; Weiss C; Koff A; Göttlicher M
Genes Dev; 1999 Jul; 13(13):1742-53. PubMed ID: 10398686
[TBL] [Abstract][Full Text] [Related]
37. Expression and hypermethylation of p27 kip1 in hepatocarcinogenesis.
Lei PP; Zhang ZJ; Shen LJ; Li JY; Zou Q; Zhang HX
World J Gastroenterol; 2005 Aug; 11(29):4587-91. PubMed ID: 16052694
[TBL] [Abstract][Full Text] [Related]
38. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
[TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of p21 and p27 genes in human pituitary adenomas.
Ikeda H; Yoshimoto T; Shida N
Br J Cancer; 1997; 76(9):1119-23. PubMed ID: 9365157
[TBL] [Abstract][Full Text] [Related]
40. Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Kawai T; Aida S; Kasamatsu H; Aurues T; Ikeda T
Mod Pathol; 2001 May; 14(5):371-6. PubMed ID: 11353044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
